A Not For Profit Organisation Signup for LEI Updates
Research Publications

Research Publications: Mariapia Degli-Esposti

Font Size

Research Publications: Mariapia Degli-Esposti

  • Ong ML, Wikstrom ME, Fleming P, Estcourt MJ, Hertzog PJ, Hill GR, Andoniou CE, Degli-Esposti MA.  CpG pretreatment enhances antiviral T-cell immunity against cytomegalovirus. Blood 2013 Jul; 122:55-60.
  • Berry R, Ng N, Saunders PM, Vivian JP, Lin J, Deuss F, Corbett AJ, Forbes CA, Widjaia J, Sullivan LC, McAlister AD, Perugini MA, Call MJ, Scalzo AA, Degli-Esposti MA, Coudert JD, Beddoe T, Brooks AG, Rossjohn J. Viral immunoevasion targeting of the Natural Killer cell receptor family. Nat Immunol. 2013 May; 14:699-705
  • Wikstrom ME, Fleming P, Comerford I, McColl SR, Andoniou CE, Degli-Esposti MA. A chemokine-like viral protein enhances IFN-α production by plasmacytoid dendritic cells but delays CD8+ T cell activation and impairs viral clearance. J Virol 2013 Jul; 87:7911-20.
  • Zinkernagel MS, Chinnery HR, Ong ML, Petitjean C, Voigt V, McLenachan S, McMenamin PG, Hill GR, Forrester JV, Wikstrom ME, Degli-Esposti MA. Interferon-g-dependent migration of microglial cells in the retina after systemic cytomegalovirus infection. Am J Pathol. 2013 182:875-885 [IF: 4.890]
  • Fleming P, Kvansakul M, Voigt V, Kile BT, Kluck RM, Huang DC, Degli-Esposti MA, Andoniou CE. MCMV-mediated inhibition of the pro-apoptotic Bak protein is required for optimal in vivo replication. PLoS Pathog. 2013 Feb;9 (2):e1003192.
  • Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mecheri S, Kaplanski G, Prevost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L. Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells. Cancer Res. 2012; 72:2757-2767 [IF: 7.856]
  • Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K, Velasco J, Strutton G, Tran A, Benham H, Rehaume L, Wilson RJ, Kikly K, Davies J, Pettit AR, Brown MA, McGuckin MA, Thomas R. Beta-glucan triggers spondyloarthropathy and Crohn’s-like ileitis in SKG mice. Arthritis Rheum. 2012; 64:2211-2222 [IF: 7.866]
  • Chinnery HR, McLenachan S, Binz N, Sun Y, Forrester JV, Degli-Esposti MA, Pearlman E, McMenamin PG. TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation. Am J Pathol. 2012; 180:209-220 [IF: 4.890]
  • Lai CM, Estcourt MJ, Himbeck RP, Lee SY, Yew-San Yeo I, Luu C, Loh BK, Lee MW, Barathi A, Villano J, Ang CL, van der Most RG, Constable IJ, Dismuke D, Samulski RJ, Degli-Esposti MA, Rakoczy EP. Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates. Gene Ther. 2011 Nov 10 [IF: 3.710]
  • Zinkernagel MS, Petitjean C, Wikstrom ME, Degli-Esposti MA. Kinetics of ocular and systemic antigen-specific T-cell responses elicited during murine cytomegalovirus retinitis. Immunol Cell Biol. 2012; 90:330-336 [IF: 3.661]
  • Zinkernagel MS, McMenamin PG, Forrester JV, Degli-Esposti MA. T cell responses in experimental viral retinitis: mechanisms, peculiarities and implications for gene therapy with viral vectors. Prog Retin Eye Res. 2011; 30:275-284 [IF: 9.455]
  • Simkins HM, Hyde E, Farrand KJ, Ong ML, Degli-Esposti MA, Hermans IF, Ronchese F. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo. J Leukoc Biol. 2011; 89:753-762 [IF: 4.992]
  • Tze LE, Horikawa K, Domaschenz H, Howard DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S, Andoniou CE, Degli-Esposti MA, Goodnow CC. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J Exp Med. 2011; 208:149-165 [IF: 13.853, 13 citations]
  • Andoniou CE, Fleming P, Sutton VR, Trapani JA, Degli-Esposti MA. Cathepsin C limits acute viral infection independently of NK cell and CD8+ T-cell cytolytic function. Immunol Cell Biol. 2011; 89:540-548 [IF: 3.661]
  • Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, Fleming P, Tabarias H, Hill GR, van der Most RG, Scalzo AA, Smyth MJ, Degli-Esposti MA. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J Exp Med. 2010; 207:1333-1343 [IF: 13.853, 36 citations]
  • Zinkernagel MS, Petitjean C, Fleming P, Chinnery HR, Constable IJ, McMenamin PG, Degli-Esposti MA. In vivo imaging of ocular MCMV infection. Invest Ophthalmol Vis Sci. 2010; 51:369-374 [IF 3.597]
  • van der Most RG, Currie AJ, Cleaver AL, Salmons J, Nowak AK, Mahendran S, Larma I, Prosser A, Robinson BWS, Smyth MJ, Scalzo AA, Degli-Esposti MA, Lake RA. Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth. PlosOne 2009;4(9):e6982 [IF: 4.092, 18 citations]
  • Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol. 2009;87:559-566 [IF: 3.661, 10 citations]
  • Lai CM, Estcourt MJ, Wikstrom M, Himbeck RP, Barnett NL, Brankov M, Tee LB, Dunlop SA, Degli-Esposti MA, Rakoczy EP. rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector. Invest Ophth Vis Sci. 2009;50:4279-87 [IF 3.597, 5 citations]
  • Banovic T, Markey KA, Kuns RD, Olver SD, Raffelt NC, Don AL, Degli-Esposti MA, Engwerda CR, MacDonald KP, Hill GR. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells. J Immunol. 182:912-20. Erratum in: J Immunol. 2009;182:3327 [IF  5.788, 16 citations]
  • Manzur M, Fleming P, Huang DC, Degli-Esposti MA, Andoniou CE. Virally mediated inhibition of Bax in leukocytes promotes dissemination of murine cytomegalovirus. Cell Death Differ. 2009;16:312-20 [IF 8.849, 8 citations]
  • Andrews DM, Andoniou CE, Fleming P, Smyth MJ, Degli-Esposti MA. The early kinetics of cytomegalovirus-specific CD8+ T cell responses are not affected by antigen load or the absence of perforin or IFN-g. J Virol, 2008;82:4931-4937 [IF: 5.402, 7 citations]
  • Huntington ND, Puthalakath H, Gunn P, Naik E, Michalak EM, Smyth MJ, Tabarias H, Degli-Esposti MA, Dewson G, Willis SN, Motoyama N, Huang DC, Nutt SL, Tarlinton DM and Strasser A. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol, 2007;8:856-863 [IF: 26.008, 57 citations]
  • Huntingdon ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, Smyth MJ, Tarlinton DM, Nutt SL. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178:4674-70 [IF: 5.788,
    44 citations]
  • van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth MJ, Degli-Esposti MA. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity. 2006;25: 835-848 [IF: 21.637, 52 citations]
  • Caminschi I, Corbett AJ, Zahra C, Lahoud M, Lucas KM, Sofi M, Vremec D, Gramberg T, Pöhlmann S, Curtis J, Handman E, van Dommelen SL, Fleming P, Degli-Esposti MA, Shortman K, Wright MD. Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN. Int Immunol. 2006;18:741-53 [IF 3.415, 17 citations]
  • Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, Delale T, Stacey KJ, Trinchieri G, Degli-Esposti MA. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective anti-viral immunity. Nat Immunol, 2005;6:1011-9 2005 [IF: 26.008, 171 citations]
  • Pao LI, Sumaria N, Kelly JM, van Dommelen SLH, Cretney E, Wallace ME, Anthony DA, Uldrich AP, Godfrey DI, Papadimitriou JM, Mullbacher A, Degli-Esposti MA, Smyth MJ. Functional analysis of granzyme M and its role in immunity to infection. J Immunol, 2005;175:3235-3243 [IF: 5.788, 31 citations]
  • Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SL, Wallace ME, Smyth MJ, Degli-Esposti MA. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol. 2005;42:547-55 [IF 2.897, 48 citations]
  • Andoniou CE, Andrews DM, Manzur M, Ricciardi-Castagnoli P, Degli-Esposti MA. A novel checkpoint in the Bcl-2-regulated apoptotic pathway revealed by infection of dendritic cells with murine cytomegalovirus. J Cell Biol, 2004;166: 827-837 [IF: 10.264, 17 citations]
  • Granucci F, Zanoni I, Pavelka N, van Dommelen SHL, Andoniou CE, Belardelli F, Degli-Esposti MA, Ricciardi-Castagnoli P.   A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med, 2004;200:287-295 [IF: 13.853,
    147 citations]
  • Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, Yokoyama WM, Scalzo AA. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA, 2003;100:13483-13488. [IF: 9.681,
    112 citations]
  • van Dommelen SLH, Tabarias HA, Smyth MJ, Degli-Esposti MA. Activation of NK1.1+ T cells enhances the anti-viral response mediated by natural killer cells during murine cytomegalovirus infection. J Virol, 2003;77:1877-1884 [IF: 5.402, 100 citations]
  • Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol. 2003;4:175-181 [IF: 26.008, 221 citations]
  • Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol. 2001;2:1077-1084 [IF: 26.008, 218 citations]
  • Andrews D, Farrell, HE, Densley EH, Scalzo AA, Shellam GR, Degli-Esposti MA. NK1.1+ cells and murine cytomegalovirus infection: what happens in-situ? J Immunol. 2001;166:1796-1802 [IF: 5.788, 39 citations]
  • Cretney E, Degli-Esposti MA, Densley E, Farrell HE, Davis-Poynter NJ, Smyth MJ. Class I MHC homologue encoded by murine CMV m144 confers tumor resistance to NK cell-mediated rejection. J Exp Med. 1999;190:435-444. [IF: 13.853, 54 citations]
  • Fleming P, Davis-Poynter NJ, Degli-Esposti MA, Densley E, Papadimitriou J, Shellam, GA, Farrell HE. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol, 1999;6800-6809. [IF: 5.402, 85 citations]
  • Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh J, Smith CA, Goodwin RG. The novel receptor TRAIL-R4 induces NFkB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity. 1997;7:813-820
    [IF: 21.637, 691 citations]
  • Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang C-P, DuBose RF, Goodwin RG, Smith CA. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 1997;186:1165-1170 [IF: 13.853,
    548 citations]
  • Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT. TRAIL-R2: A novel apoptosis mediating receptor for TRAIL. EMBO J 1997;16:5386-5397
    [IF: 9.205, 853 citations]
  • Degli-Esposti MA, Davis-Smith T, Din W, Smolak PJ, Goodwin RG, Smith CA. Activation of the lymphotoxin b receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. J Immunol 1997;158:1756-1762 [IF: 5.788,
    54 citations]
  • Leelayuwat C, Hollingsworth P, Pummer S, Lertmemongkolchai G, Thom G, Mullberg J, Witt C, Kaufman J, Degli-Esposti MA, Cosman D, Dawkins RL. Antibody reactivity profiles following immunization with diverse peptides of the PERB11 (MIC) family. Clin Exp Immunol. 1996;106:568-576 [IF: 3.360, 13 citations]
  • Townend DC, Gaudieri S, Leelayuwat C, Tay GK, Degli-Esposti MP, Dawkins RL. Genomic structure of a 200kb region between HLA-C and TNF: implications for transplantation, autoimmune disease and evolution. DNA Sequence. 1996;7:55-59
  • Degli-Esposti MA, Leelayuwat C, Daly LN, Carcassi C, Contu L, Versluis LF, Tilanus MGJ, Dawkins RL. Updated characterization of ancestral haplotypes using the Fourth Asia-Oceania Histocompatibility Workshop panel. Hum Immunol. 1995;44:12-18 [IF: 2.837, 42 citations]
  • Versluis LF, Daly LN, Degli-Esposti MA, van der Zwan AW, Dawkins RL, Tilanus MG. Identification of the novel HLA-DPB1*5801 allele detected by sequenced based typing. Immunogenetics. 1995;41:173 [IF: 2.934]
  • Leelayuwat C, Degli-Esposti MA, Taylor E, Abraham LJ, Dawkins RL. PCR SSCP reveals haplotype related polymorphisms of Perb1: a new marker for MHC b block typing. Eur J Immunogenetics 1994;21:431-446 [IF: 1.23, 5 citations]
  • Leelayuwat C, Townend DC, Degli-Esposti MA, Abraham LJ, Dawkins RL. A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics. 1994;40:339-351 [IF: 2.934, 114 citations]
  • Degli-Esposti MA, Griffiths MS, Daly LN, Witt C, Simons M, Carcassi C, Albert E, Giphart MJ, Dawkins RL. Characterization of 4AOHW cell line panel including new data for the 10IHW panel. Hum Immunol 1993;38:3-16. [IF: 2.837, 29 citations]
  • Degli-Esposti MA, Williamson JF, Tay GK, Salmon B, Joseph GA, Morley AA, Dawkins RL. 1993. Genomic MHC haplotyping of mutant cell lines using a novel marker. Eur J Immunogen. 1993;20:373-380 [IF: 1.23]
  • Marshall B, Leelayuwat C, Degli-Esposti MA, Pinelli M, Abraham LJ, Dawkins RL. New major histocompatibility complex genes. Hum Immunol 1993;38:24-29 [IF: 2.837,
    47 citations]
  • Thomsen M, Witt C, Degli-Esposti MA, Christiansen FT. Typing of 4AOHW cells by allospecific natural killer cells. Hum Immunol 1993;38: 52-56 [IF: 2.837]
  • Chan SH, Tan CB, Lin YN, Wee GB, Degli-Esposti MA, Dawkins RL. HLA and Singaporean Chinese myasthenia gravis. Int Arch Allergy Immunol 1993;101:119-125  [IF: 2.403, 14 citations]
  • Degli-Esposti MA, Leaver AL, Christiansen FT, Witt C, Abraham LJ, Dawkins RL. Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol. 1992;34: 242-252 [IF: 2.837, 181 citations]
  • Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 1992;36:345-356 (IF: 2.934, 92 citations]
  • Degli-Esposti MA, Andreas A, Christiansen FT, Schalke B, Albert E, Dawkins RL. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics. 1992;35:355-364
    [IF: 2.934, 121 citations]
  • Degli-Esposti MA, Dallas PD, Dawkins RL. Neuromuscular function and polymorphism of the acetylcholine receptor gamma gene. Muscle Nerve. 1992;15:543-549 [IF: 2.367]
  • Degli-Esposti MA, Leelayuwat C, Dawkins RL. Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: possible relevance to autoimmune disease. Eur J Immunogen. 1992;19:121-127 [IF: 1.23, 11 citations]
  • Abraham LJ, Leelayuwat C, Grimsley G, Degli-Esposti MA, Mann A, Zhang WJ, Christiansen FT, Dawkins RL. Sequence differences between HLA-B and TNF distinguish different MHC ancestral haplotypes. Tissue Antigens. 1992;39:117-121
    [IF: 2.588, 29 citations]
  • Abraham LJ, Grimsley G, Zhang WJ, Degli-Esposti MA, Dawkins RL. Polymorphism in the human B144 gene in different MHC haplotypes. Eur J Immunogen. 1992;19:165-168.  [IF: 1.23, 6 citations]
  • Zhang WJ, Degli-Esposti MA, Cobain TJ, Cameron PU, Christiansen FT, Dawkins RL. Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis.
    J Exp Med 1992;171:2101-2114 [IF: 13.853, 60 citations]
  • Abraham LJ, Degli-Esposti MA, Zhang WJ, Christiansen FT, Dawkins RL. Mapping autoimmune disease susceptibility genes in the Major Histocompatibility Complex. Proc Aust Physiol Pharm Soc 1991;22:201-203
  • Dawkins RL, Zhang WJ, Degli-Esposti MA, Abraham L, McCann V, Christiansen FT. Studies of MHC haplotypes by pulsed field gel-electrophoresis. Baillieres Clinical Endocrinology and Metabolism. 1991;5:285-297 [IF: 4.121, 8 citations]
  • Forrester JV, Steptoe RJ, Klaska IP, Martin-Granados C, Dua HS, Degli-Esposti MA, Wikstrom ME. Cell-based therapies for ocular inflammation. Prog Retin Eye Res. 2013 Jul; 35:82-101.
  • Andoniou C, Coudert JD, Degli-Esposti MA. Killers and beyond: NK-cell-mediated control of immune responses. Eur J Immunol. 2009;38:2938-42 Review [IF 5.103, 25 citations]
  • Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol. 2007;85:46-54 Review [IF 3.661, 40 citations]
  • Andoniou CE, Andrews DM, Degli-Esposti MA. Natural killer cells in viral infection: more than just killers. Immunol Review. 2006;14:239-50 Review [IF 11.148, 40 citations]
  • Andoniou CE, Degli-Esposti MA. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol. 2006;84:99-106 Review [IF 3.661, 31 citations]
  • Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: DCs and NK cells take centre stage. Nat Rev Immunol. 2005 Feb;5(2):112-24 Review [IF: 33.287, 328 citations]
  • van Dommelen SLH, Degli-Esposti MA. NKT cells and viral immunity. Immunol Cell Biol. 2004;82:332-341 Review [IF: 3.661, 17 citations]
  • Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SLH, Wallace ME, Smyth MJ, Degli-Esposti MA. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol. 2005;42:547-555Review [IF: 2.897, 47 citations]
  • Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SEA, Yagita H, Takeda K, van Dommelen SLH, Degli-Esposti MA, Hayakawa Y. Activation of NK cell cytotoxicity.  Mol Immunol. 2005;42:501-510 Review [IF: 2.897, 193 citations]
  • Granucci F, Andrews DM, Degli-Esposti MA, Ricciardi-Castagnoli P. IL-2 mediates adjuvant effect of dendritic cells. Trends in Immunology. 2002;23:169-171 Review
    [IF: 10.403, 36 citations]
  • Farrell HE, Davis-Poynter NJ, Andrews DM, Degli-Esposti MA. Function of CMV-encoded MHC class I homologues.  Curr Top Microbiol Immunol. 2002;269:131-151 Review [IF: 4.925, 10 citations]
  • Farrell H, Degli-Esposti M, Densley E, Cretney E, Smyth M, Davis-Poynter N. Cytomegalovirus MHC class I homologues and natural killer cells: an overview. Microbes Infect. 2000;2:521-532 Review [IF: 3.103, 13 citations]
  • Degli-Esposti M. To die or not to die – The quest of the TRAIL receptors. J Leuk Biol. 1999;65:535-542 Review [IF: 4.992, 136 citations]
  • Farrell HE, Degli-Esposti MA, Davis-Poynter NJ. Cytomegalovirus evasion of natural killer cell responses. Immunol Rev. 1999;168:187-197 Review [IF: 11.148, 38 citations]
  • Davis-Poynter NJ, Degli-Esposti M, Farrell HE. Murine cytomegalovirus homologues of cellular immunomodulatory genes. Intervirology. 1999;42:331-341 Review [IF: 2.337,
    9 citations]
  • Benedict CA, Crozat K, Degli-Esposti M and Dalod M. Host genetic models in cytomegalovirus immunology. In Cytomegaloviruses: From Molecular Pathogenesis to Intervention edited by MJ Reddehase. 2013. Volume II, chapter 12.
  • Coudert JD, Andoniou CE and Degli-Esposti MA. Cytomegalovirus infection and NK cells. In Natural killer cells: Basic science and clinical application, edited by MT Lotze and AW Thomson. 2010. Pages 499-510.
  • van Dommelen SLH, Andrews DM, Scalzo AA, Degli-Esposti MA.  2003. Analysis of murine NK and NKT cells during viral infection. In Methods in Molecular Biology, edited by JA Katz.  Humana Press, Towata, New Jersey.
  • Degli-Esposti MA, Townend DC, Smith LK, Finley JM and Dawkins RL. 1992. Complotypes and ancestral haplotypes: associations with autoimmune disease.  In HLA 1991, Tsuji K, Aizawa M and Sasazuki T (eds) Oxford University Press, NY, Vol 1: 984-985.
  • Degli-Esposti MA, Chiewsilp P, Boongird P, Visudhiphan P, Chan SH, Tan CB, Illeni MT, Pellegris G, Bach JF, Caillat-Zucman S, Moriuchi J, Arimori S, Mehra N and Dawkins RL. 1992. Myasthenia Gravis – Disease Report.  In HLA 1991, Tsuji K, Aizawa M and Sasazuki T (eds) Oxford University Press, NY, Vol 1: 761-764.
  • Degli-Esposti MA, Abraham LJ, Witt C, Cameron PU, Zhang WJ, Christiansen FT and Dawkins RL. 1992. Ancestral haplotypes are conserved population haplotypes with a unique MHC structure. In HLA 1991, Tsuji K, Aizawa M and Sasazuki T (eds) Oxford University Press, NY, Vol 2: 169-172.
  • Leelayuwat C, Abraham LJ, Tabarias H, Mann A, Grimsley G, Degli-Esposti MA, Zhang WJ, Christiansen FT and Dawkins RL. 1992. Haplospecific polymorphisms in a duplicated region centromeric of HLA-B.  In HLA 1991, Tsuji K, Aizawa M and Sasazuki T (eds) Oxford University Press, NY, Vol 2: 172-175.
  • Zhang WJ, Wu X, Witt C, Leelayuwat C, Abraham LJ, Grimsley G, Degli-Esposti MA, Christiansen FT and Dawkins RL. 1992. New genomic markers between the HLA-B and TNF loci define MHC ancestral haplotypes.  In HLA 1991, Tsuji K, Aizawa M and Sasazuki T (eds) Oxford University Press, NY, Vol 2: 176-179.
  • Dawkins RL, Degli-Esposti MA, Abraham LJ, Zhang WJ and Christiansen FT. 1991. Conservation versus polymorphism of the MHC in relation to transplantation, immune response and autoimmune disease. In Molecular Evolution of the MHC,  Klein J and Klein D (eds) Springer-Verlag, Heidelberg, NATO ASI Series, Vol H59: 391-402.
  • Dawkins RL, Zhang WJ, Degli-Esposti MA, Abraham LJ, McCann V and Christiansen FT. 1991. Genetics of diabetes. Studies of MHC haplotypes by pulsed field gel electrophoresis. In Baillieres Clinical Endocrinology and Metabolism, The genetics of Diabetes, Tait B and Harrison L (eds) Vol 5, Chapt 5: 285-297.
  • French M, Dawkins RL, Christiansen FT, Zhang WJ, Degli-Esposti MA and Saueracker G. 1991. Central MHC genes, IgA deficiency and autoimmune disease – reply to Olerup and colleagues. Immunology Today 12: 135-136.  now Trends in Immunology [IF: 13.08]

Stay updated
on LEI News

Let's get Social - /lionseyeinstitute

Like to stay up to date? Subscribe for LEI updates and be the first to know.
  • This field is for validation purposes and should be left unchanged.